A nurse is planning to lead a support group for clients who have alcohol use disorder. One of the group members is a client who speaks a different language than the nurse. The nurse should ask which of the following individuals to assist with communication?

A. The client expresses feelings of guilt.
Feelings of guilt are a common part of the grieving process. Many people may experience guilt related to things they said or didn't say, things they did or didn't do before their loved one's death. While it can be challenging, it is not necessarily a maladaptive grief response.

B. The client is unable to perform basic hygiene tasks.
This indicates a maladaptive grief response. If the client's grief has led to such severe impairment in functioning that they cannot maintain basic hygiene, it suggests an inability to cope and function in daily life, which is concerning and requires intervention and support.

C. The client gives away some of the partner's belongings.
This behavior is a common part of the grieving process. It can represent the client's attempt to let go and move on. It might also be an expression of their partner's wishes or a way to help others in need. Giving away belongings is not inherently maladaptive; it depends on the context and the individual's overall coping abilities.

D. The client relocates from a house to an apartment.
Changes in living arrangements after the loss of a loved one are often part of adapting to the new circumstances. It can be a way for the individual to reduce their responsibilities, live in a more manageable space, or seek a fresh start. Relocating, on its own, is not a maladaptive response to grief.

A. Liraglutide 0.6 mg subcutaneously daily:
Liraglutide is a medication used to treat type 2 diabetes and obesity. It works by regulating blood sugar levels and reducing appetite. It has no direct relevance to the treatment of schizophrenia or psychosis. Schizophrenia is a mental health disorder, and antipsychotic medications are typically used to manage its symptoms.

B. Selegiline 6 mg transdermal patch daily:
Selegiline is primarily used to treat Parkinson's disease by enhancing the effects of dopamine in the brain. It is not indicated for schizophrenia or psychosis. While dopamine dysregulation is involved in both Parkinson's disease and schizophrenia, the mechanisms and treatments are different. Antipsychotic medications, not selegiline, are used to manage psychosis in schizophrenia.

C. Aripiprazole 400 mg IM every 4 weeks:
This is the correct choice. Aripiprazole is an atypical antipsychotic medication commonly used to treat schizophrenia and other psychotic disorders. The intramuscular (IM) formulation provides extended release, making it suitable for clients who may have difficulty adhering to daily oral medications. It helps manage psychosis, a common symptom of schizophrenia.

D. Lithium 600 mg PO three times per day:
Lithium is a mood stabilizer commonly used to treat bipolar disorder by preventing or reducing the intensity of manic episodes. It is not a first-line treatment for schizophrenia or psychosis. Antipsychotic medications are the primary choice for managing the symptoms of psychosis in schizophrenia. Lithium is not typically used to address the hallucinations and delusions associated with schizophrenia.